Medical Advisory Board
Maureane Hoffman, MD, PhD, is Professor of Pathology at Duke University and Director of the Hematology, Transfusion Service and Clinical Chemistry Laboratories at the affiliated Durham VA Medical Center. In this capacity, she has strong interests and experience in component therapy for bleeding disorders and mechanisms for monitoring anticoagulants and transfusion therapy. Hoffman’s research focuses on the role of cellular features in controlling hemostasis and thrombosis. Her collaboration with Drs. Mac Monroe and Harold Roberts has led to the development of an in vitro cell-based model that mimics many aspects of hemostasis in vivo. This work has produced an improved conceptual model of how the hemostatic process functions in vivo. She has authored or co-authored more than 115 journal articles and 15 book chapters and has lectured extensively in the US and Europe on basic and clinical laboratory aspects of coagulation. She obtained her MD and PhD (Pharmacology/Toxicology) degrees from the University of Iowa. She completed residency training in Anatomic and Clinical Pathology at Duke University.
Pär I. Johansson, MD, DSc, MBA, is Director of Transfusion Medicine and Head of the Haemostasis Research Laboratory at the Capital Region Blood Bank, Rigshospitalet, the National University Hospital in Copenhagen, Denmark. He is by training a specialist in Anesthesiology, Clinical Immunology and Transfusion Medicine and his research is focusing on the interplay between the haemostatic, inflammatory and innate immune systems in critical illness and trauma. A particular research interest concerns exploring the clinical utility of whole blood functional haemostatic assays in patients with critical illness including critical hemorrhage. He has published more than 60 peer reviewed scientific manuscripts and he is a member of several international research collaborations. He is Chairman of the International Symposium on Critical Bleeding and has served as an invited speaker at more than 50 international scientific meetings concerning critical bleeding, hemostasis and resuscitation strategies in trauma and major surgery. He obtained his medical degree from the University of Lund and his Doctor of Medical Science from the University of Copenhagen.
Linda Shore-Lesserson, MD, is Professor of Anesthesiology at Hofstra North Shore- LIJ School of Medicine in New York. She is a diplomate of the National Board of Medical Examiners, American Board of Anesthesiology and National Board of Echocardiography. She is currently President of the Society of Cardiovascular Anesthesiologists. She is also Chair of the Committee on Patient Blood Management of the American Society of Anesthesiologists and sits on the scientific program committee for the New York State Society of Anesthesiologists PGA Annual Meeting. Her research interests lie in the field of hemostasis and thrombosis as it relates to cardiovascular disease. The results of her research have been published in high-impact peer reviewed journals. She lectures frequently at national and international scientific meetings having accomplished more than 100 visiting professorships and invited lectures. Shore-Lesserson received her medical degree from the University of Pennsylvania.
Bruce Spiess, MD, FAHA, is a Professor and the Associate Chief for Research within the Department of Anesthesiology at the University of Florida. He has published more than 150 academic research manuscripts focusing on risks of blood transfusion, coagulation dysfunction with heart surgery and oxygen therapeutics “blood substitutes.” He spearheads a research group applying perfluorocarbon emulsions in unique ways to preserve tissue. Spiess served as editor on the second edition of “Perioperative Blood Transfusion,” an authoritative text regarding risks and benefits of transfusion with all types of surgery. Most recently he has collaborated in the founding of VCURES shock research institute at Virginia Commonwealth University and continues to push to understand oxygen transport for critically ill patients therapeutics “blood substitutes”. He obtained his MD from Rush University.